Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.73M | 1.70M | 123.00K | 126.50K | 557.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.73M | 1.70M | 123.00K | 126.50K | 557.40K |
| Cost of Revenue | 820.90K | 803.90K | 393.80K | 404.90K | 881.10K |
| Gross Profit | 912.40K | 893.50K | -270.80K | -278.40K | -323.70K |
| SG&A Expenses | 16.86M | 16.51M | 9.78M | 10.06M | 2.44M |
| Depreciation & Amortization | 367.00K | 359.40K | 364.30K | 374.60K | 21.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.05M | 17.68M | 10.54M | 10.84M | 3.35M |
| Operating Income | -16.32M | -15.98M | -10.42M | -10.71M | -2.79M |
| Income Before Tax | -17.78M | -17.41M | -10.06M | -10.35M | -2.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.78M | -17.41M | -10.06M | -10.35M | -2.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.78M | -17.41M | -10.06M | -10.35M | -2.77M |
| EBIT | -16.32M | -15.98M | -10.42M | -10.71M | -2.79M |
| EBITDA | -15.95M | -15.62M | -10.05M | -10.34M | -2.77M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.87B | 1.87B | 1.82B | 1.82B | 1.56B |
| Average Diluted Shares Outstanding | 1.87B | 1.87B | 1.82B | 1.82B | 1.56B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |